Home › Calculator › MLLCF Dividend Calculator 2026
MLLCF Dividend DRIP Calculator 2026
52.63% YieldHealthcareMolecular Partners AG · OTC
Price: $3.80 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When MLLCF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your MLLCF snowball 📈
$10,000 in MLLCF → $2562702140.18M in 10 years · $213,162,994,407,136.12/month
About Molecular Partners AG (MLLCF) — Dividend Analysis 2026
Molecular Partners AG, a clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland. Its product pipeline comprises MP0317, which is in Phase 2 clinical trial for the treatment of advanced solid tumors; MP053, novel tetra-specific T cell-engaging DARPin, which is phase 1 clinical trial for the treatment of acute myeloid leukemia; and MP0712, a 212Pb Radio-DARPin therapy (RDT) candidate targeting the tumor-associated protein delta-like ligand 3 (DLL3) which is in Phase 1 clinical trial to treat SCLC and neuroendocrine tumors. It also researches for Switch-DARPin T cell engager to treat CD3 x costim x; and MP0726, a Radio-DARPin Therapy to treat ovarian cancer and other MSLNexpressing cancers. In addition, the company develops MP0621, a Switch-DARPin candidate targeting CD16a, c-KIT, and CD47 as conditioning for hematopoietic stem cell transplantation; and Radio-DARPin Therapy (RDT) platform, a delivery system for effective and selective delivery of radioactive payloads to solid tumors. It has collaboration agreement with Orano Med SAS to develop novel Radio-DARPin therapeutics and an additional six targeted alpha therapeutics candidates and Eckert & Ziegler SE to develop Radio-DARPin therapeutics. Molecular Partners AG was incorporated in 2004 and is headquartered in Schlieren, Switzerland.
Compare MLLCF with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full MLLCF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open MLLCF position with:
🌍 MLLCF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold MLLCF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 52.63% | 49.83% | $5,263 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 44.74% | 41.94% | $4,474 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 42.10% | 39.30% | $4,210 / yr |
| 🇬🇧 UK ISA | 0% | 52.63% | 49.83% | $5,263 / yr |
| 🇬🇧 UK Taxable | 8.75% | 48.02% | 45.22% | $4,802 / yr |
| 🇨🇦 TFSA | 0% | 52.63% | 49.83% | $5,263 / yr |
| 🇨🇦 CA Taxable | 25% | 39.47% | 36.67% | $3,947 / yr |
| 🇦🇺 Super (pension) | 15% | 44.74% | 41.94% | $4,474 / yr |
| 🇦🇺 AU Taxable | 30% | 36.84% | 34.04% | $3,684 / yr |
| 🇩🇪 DE Taxable | 26.375% | 38.75% | 35.95% | $3,875 / yr |
| 🇫🇷 FR Taxable | 30% | 36.84% | 34.04% | $3,684 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 MLLCF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 MLLCF Dividend Payment Schedule
MLLCF pays quarterly — 4 times per year. Next ex-div: TBD.
📊 MLLCF vs Healthcare Benchmarks
How MLLCF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for MLLCF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ MLLCF Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the MLLCF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Molecular Partners AG (MLLCF) is currently trading at $3.80, 87% below its 52-week high. The current dividend yield is 52.63% based on an annual payout of $2.00 per share.
MLLCF (Molecular Partners AG) — 52.63% Dividend Yield Analysis
Molecular Partners AG (MLLCF) is a healthcare stock currently trading at $3.80 with a dividend yield of 52.63%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (52.63%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.